Authors
Latest:
Cultural Competence Sets Pharmacy Professionals ApartTraining and knowledge about appropriate communication with individuals of diverse backgrounds improves adherence, outcomes.
Latest:
SGLT2 Inhibitors Are Underutilized for Inpatient Heart Failure TreatmentCardioprotective antihyperglycemic agents are underutilized for inpatient care in heart failure patients. Lack of use can lead to preventable patient deaths and hospital readmissions.
Latest:
Good Samaritan Laws Aim to Encourage AssistanceBut in real-world situations, such as when a bystander administers naloxone, there are gray areas.
Latest:
Baby Steps to a Healthier You: Prioritizing Lifestyle Changes Over MedicationTake these 4 steps to help prevent health conditions and disease naturally.
Latest:
Updates on 2022 Changes to the American Diabetes Association Standards of CareMetformin has been the drug of choice for the treatment of diabetes since the 1950s, but new changes suggest the consideration of SGLT-2 inhibitors or GLT-1 agonists.
Latest:
Changing the Game: Pharmacy Students' Perspective on Naloxone OTC ApprovalTo eliminate the existing stigma in the community, addiction must be recognized as a treatable condition rather than an immoral act.
Latest:
Lung Cancer Study Brings Pharmacists to the Forefront of Patient CarePharmacists have always been a vital member of the cancer care team, but the emergence of many new oral therapies is making their role in patient care a more prominent one.
Latest:
HER2 and HER3 in NSCLC: The Latest ADC Data and NCCN Guideline UpdatesCorrine Stahura, PharmD, and Sophia Gilardone, PharmD, BCOP, discuss recent clinical trial data and evolving guideline recommendations for HER2- and HER3-directed antibody-drug conjugates (ADCs) in non–small cell lung cancer (NSCLC), highlighting differences in efficacy, safety, and patient selection criteria.
Latest:
How Specialty Pharmacies Can Increase Access Through Patient FinancingIt’s essential that health care providers across the patient journey demystify the costs of treatment and provide solutions to overcome the financial barriers.
Latest:
A Review of Oral Cephalosporins for Common Outpatient InfectionsCephalosporins are commonly prescribed in the outpatient setting; understanding differences among them is important for pharmacists.
Latest:
Clinical Overview: Comparison of Anti-Amyloid Monoclonal Antibodies for Alzheimer DiseaseAducanumab, lecanemab, and donanemab are novel monoclonal antibodies designed to slow disease progression and hopefully have a positive impact in the field of Alzheimer disease management.
Latest:
Looking Toward the Future of CDI ManagementClosing out their discussion on Clostridioides difficile infection, panelists share closing thoughts on novel pipeline therapies.
Latest:
ASCO 2025: Stratifying NSCLC Treatment by HER2-Alteration SubtypeNikita Dahake, MD; Hossein Borghaei, DO, MS; and Yasmine Baca, MS, PhD candidate, MB(ASCP)CM, explore how distinct HER2-alteration subtypes in non-small cell lung cancer (NSCLC) impact survival outcomes, co-mutation profiles, and treatment response to immunotherapy-based regimens.
Latest:
Pharmacy Technicians as Non-Pharmacist Preceptors for a Sterile Compounding RotationRecognizing pharmacy technicians as non-pharmacist preceptors can provide an opportunity for professional development while encouraging technicians to practice at the top of their education and training activities.
Latest:
GOLD Guidelines Provide Recommendations on Managing COPDPivotal resource helps health care professionals diagnose, manage, and prevent this group of lung diseases.
Latest:
Clinical Overview: Treatment Recommendations for Pneumococcal DiseaseTreatment for community-acquired pneumococcal disease is dependent on patient-specific factors, whereas prevention with vaccinations is dependent on age and comorbidities.
Latest:
Equitable Representation in Triple-Negative Breast Cancer Clinical TrialsBlack women have higher rates of triple-negative breast cancer (TNBC) incidence and mortality than the general US population. Despite this, they are underrepresented in TNBC clinical trials.
Latest:
Building Bridges: Multidisciplinary Care and Patient Education Excellence for TDPanelists discuss how pharmacists play a vital role in ensuring personalized care for tardive dyskinesia patients by fostering continuous, secure communication and collaboration with health care teams across various practice settings.
Latest:
Point-of-Care Testing Offers New Opportunities for Pharmacy TechniciansBecoming experts in medical billing for point-of-care testing offers a new avenue for technicians to excel and show their value.
Latest:
Revolutionizing Outpatient Oncology Care: The Seamless Integration of Artificial IntelligenceArtificial intelligence holds immense potential to address the rising demand for oncology services and improve patient outcomes by facilitating more effective, efficient, personalized cancer care.
Latest:
Practical Considerations of T-Cell Engagers in the Management of Relapsed/Refractory Multiple MyelomaIntegration of these agents requires supportive care considerations for cytokine release syndrome, neurotoxicity, infection, and antigen-specific toxicities to ensure optimal care of patients with multiple myeloma receiving T-cell–engaging therapies.
Latest:
Proper Use of Automation in Hazardous Drug Compounding PharmaciesAlthough robotics can be instrumental in assuring sterility and reducing the overall number of potential hazardous drug exposure events, certain tasks require vigilant oversight.
Latest:
NCCN Flash Update: Linvoseltamab Added as Preferred Regimen After 4 Prior Therapies for Multiple MyelomaThe National Comprehensive Cancer Network (NCCN) has released multiple myeloma guidelines version 2.2026 to include linvoseltamab as a preferred treatment for heavily pretreated patients, highlighting its intravenous formulation, dosing options, and streamlined Risk Evaluation and Mitigation Strategy program.
Latest:
Specialty Drug Commercialization Process and ConsiderationsAs specialty drugs move through clinical trials and preparations for commercialization begin, significant attention is warranted to this process considering the massive investments that would have been already made in the product up to this point.
Latest:
Use of Lutetium Lu-177 Vipivotide Tetraxetan to Treat Metastatic Castration-Resistant Prostate CancerThe FDA-approved, targeted radiopharmaceutical agent can contribute to a patient’s cumulative radiation exposure.
Latest:
Only a Phone Call Away: The Development of a Transplant Telepharmacy Consult Service For a Large Medical SystemTransplant patients must adhere to lifelong regimens and those caring for them must consider their regimen as the patients intersect with different parts of the health care system.
Latest:
Making “Rheum” for Biosimilars: Overcoming ReluctanceDespite the proven efficacy of biosimilars, both patients and health care providers often have some reluctance when switching from an originator drug to a biosimilar.
